Remedica est spécialisée dans le développement et la fourniture de produits pharmaceutiques pour l’octroi de licences. Il offre des opportunités attractives d’octroi de licences aux entreprises à travers le monde dans un large éventail de domaines thérapeutiques. Les dossiers proposés sont conformes à toutes les normes internationales et européennes applicables. Remedica travaillera avec vous pour trouver la solution la plus rentable qui soit, dans le but de devenir un partenaire durable offrant des solutions sur mesure, en fonction de vos besoins et exigences spécifiques.
| GENERIC NAME | STRENGTH and DOSAGE FORM | THERAPEUTIC CATEGORY | DOSSIER AVAILABILITY |
|---|---|---|---|
| ABACAVIR / LAMIVUDINE** | 600mg/300mg Film-coated tablets | Antivirals | YES |
| ABIRATERONE ACETATE** | 250mg and 500mg Film-coated tablets | Antineoplastic agents | YES |
| ACETYLSALICYLIC ACID | 75mg Gastro-resistant tablets | Antithrombotic agents | Q3-2024 |
| ACICLOVIR | 200mg, 400mg, 800mg Tablets | Antivirals | Q4-2024 |
| ALLOPURINOL | 100mg, 300mg Tablets | Antigout | Q2-2022 |
| AMIODARONE | 200mg Tablets | Antiarrhythmics | Q3-2024 |
| AMITRIPTYLINE | 10mg, 25mg Film-coated tablets | Antidepressants | Q2-2023 |
| AMOXICILLIN | 250mg, 500mg Capsules, hard | Antibacterials | YES |
| AMOXICILLIN | 125mg/5ml, 250mg/5ml Powder for oral suspension | Antibacterials | Q3-2024 |
| AMOXICILLIN / CLAVULANIC ACID | 875/125mg Film-coated Tablets | Antibacterials | Q3-2023 |
| AMOXICILLIN / CLAVULANIC ACID | 500mg/125mg Film-coated tablets | Antibacterials | Q3-2022 |
| ANASTROZOLE ** | 1mg Film-coated tablets | Antineoplastic agents | YES |
| APIXABAN ** | 2.5mg, 5mg Film-coated tablets | Antithrombotic agents | Q1-2025 |
| ATAZANAVIR ** | 100mg, 150mg, 200mg, 300mg Capsules, hard | Antivirals | YES |
| AZATHIOPRINE | 50mg Film-coated tablets | Immunosuppressants | Q4-2022 |
| AZITHROMYCIN | 125mg, 250mg, 500mg Film-coated tablets | Antibacterial | Q3-2023 |
| BISACODYL | 5mg Gastro-resistant tablets | Laxatives | Q1-2023 |
| BROMAZEPAM | 1.5mg, 3mg, 6mg Tablets | Anxiolytics | Q3-2023 |
| CALCIUM LACTATE PENTAHYDRATE | 300mg Tablets | Supplements | Q4-2021 |
| CAPECITABINE ** | 150mg, 500mg Film-coated tablets | Antineoplastic agents | YES |
| CARBAMAZEPINE | 200mg Tablets | Antiepileptics | Q3-2022 |
| CARBAMAZEPINE | 400mg Prolonged-release tablets | Antiepileptics | Q1-2024 |
| CARBIMAZOLE | 5mg Tablets | Antithyroid agents | Q1-2023 |
| CEFIXIME | 200mg, 400mg Film-coated tablets | Antibacterials | Q1-2024 |
| CEFALEXIN | 250mg, 500mg Capsules, hard | Antibacterials | Q3-2023 |
| CEFPODOXIME PROXETIL | 100mg, 200mg Film-coated tablets | Antibacterials | Q2-2024 |
| CEFUROXIME | 125mg, 250mg, 500mg Film-coated tablets | Antibacterial | Q1-2023 |
| CHLORPROMAZINE | 25mg, 50mg,100mg Film-coated tablets | Antipsychotics | Q1-2024 |
| CINACALCET ** | 30mg, 60mg, 90mg Film-coated tablets | Anti-parathyroid agents | YES |
| CIPROFLOXACIN | 250mg, 500mg, 750mg Film-coated tablets | Antibacterials | Q3-2022 |
| CLARITHROMYCIN | 250mg, 500mg Film-coated tablets | Antibacterials | YES |
| CLONAZEPAM | 0.5mg, 2mg Tablets | Antiepileptics | Q4-2023 |
| CLOZAPINE | 25mg, 100mg Film-coated tablets | Antipsychotics | YES |
| DAPOXETINE HYDROCHLORIDE | 30mg, 60mg Film-coated tablets | N/A | Q4-2022 |
| DARUNAVIR ** | 75mg, 150mg, 300mg, 400mg, 600mg, 800mg Film-coated tablets | Antivirals | YES |
| DASATINIB ** | 20mg, 50mg, 70mg, 80mg, 100mg, 140mg Film-coated tablets | Antineoplastic agents | YES |
| DIAZEPAM | 2mg, 5mg, 10mg Tablets | Anxiolytics | Q4-2024 |
| DICLOFENAC SODIUM | 25mg, 50mg Gastro-resistant tablets | Antiinflammatory | Q3-2022 |
| DICLOFENAC SODIUM | 100mg Prolonged-release tablets | Antiinflammatory | Q1-2025 |
| DOLUTEGRAVIR | 10mg, 25mg, 50mg Film-coated tablets | Antivirals | Q4-2026 |
| DONEPEZIL | 5MG, 10mg, Film-coated tablets | Anti-dementia agent | Q1-2025 |
| DOXYCYLCINE | 100mg Film-coated tablets | Antibacterials | Q3-2024 |
| DOXYCYLCINE | 100mg Capsules, hard | Antibacterials | Q4-2025 |
| EFAVIRENZ / EMTRICITABINE / TENOFOVIR DISOPROXIL ** | 600mg/200mg/245mg Film-coated tablets | Antivirals | YES |
| EMTRICITABINE / TENOFOVIR DISOPROXIL ** | 200mg/245mg Film-coated tablets | Antivirals | YES |
| ENALAPRIL MALEATE | 5mg, 10mg, 20mg Tablets | ACE inhibitors | Q4-2021 |
| ENTECAVIR ** | 0.5mg, 1mg Film-coated tablets | Antivirals | YES |
| ERLOTINIB ** | 25mg, 50mg, 100mg, 150mg Film-coated tablets | Antineoplastic agents | YES |
| ERYTHROMYCIN | 125mg/5ml, 250mg/5ml Powder for oral suspension | Antibacterials | Q2-2024 |
| ERYTHROMYCIN | 250mg, 500mg Film-coated tablets | Antibacterials | Q2-2025 |
| ESCITALOPRAM | 5mg, 10mg, 20mg Film-coated tablets | Antidepressants | Q4-2022 |
| EXEMESTANE | 25mg Film-coated tablets | Antineoplastic agents | YES |
| FAMOTIDINE | 20mg, 40mg Film-coated tablets | Antiulcerants & antireflux agents | Q2-2024 |
| FERROUS FUMARATE | 200mg Film-coated tablets | Antianemic preparations | Q3-2023 |
| FERROUS FUMARATE / FOLIC ACID | 185mg/0.4mg, 310mg/0.35mg Film-coated tablets | Antianemic preparations | Q3-2023 |
| FEXOFENADINE | 120mg, 180mg Tablets | Antihistamines | Q4-2024 |
| FUROSEMIDE | 40mg Tablets | Diuretics | Q2-2025 |
| GEFITINIB ** | 250mg Film-coated tablets | Antineoplastic agents | YES |
| GRISEOFULVIN | 125mg, 500mg Tablets | Antifungals | Q4-2023 |
| HYDRALAZINE | 25mg Film-coated tablets | Antihypertensives | Q1-2023 |
| HYOSCINE BUTYLBROMIDE | 10mg Coated tablets | Gastrointestinal disorder drugs | Q4-2023 |
| IBUPROFEN | 200mg, 400mg, 600mg Film-coated tablets | Antiinflammatory & antirheumatics | Q1-2022 |
| IMATINIB ** | 100mg, 400mg Film-coated tablets | Antineoplastic agents | YES |
| IVABRADINE ** | 5mg, 7.5mg Film-coated tablets | Antiischemic preparation | YES |
| LAPATINIB ** | 250mg Film-coated tablets | Antineoplastic agents | Q3-2021 |
| LETROZOLE | 2.5mg Film-coated tablets | Antineoplastic agents | Q1-2022 |
| LEVODOPA / CARBIDOPA | 250mg/25mg, 100mg/25mg, 100mg/10mg Tablets | Antiparkinsons drugs | Q2-2023 |
| LINAGLIPTIN** | 5mg Film-Coated Tablets | Diabetes drugs | Q4-2024 |
| LINAGLIPTIN / METFORMIN ** | 2.5mg/850mg, 2.5mg/1000mg, 5mg/1000mg Film-Coated Tablets | Diabetes drugs | Q4-2024 |
| METFORMIN HYDROCHLORIDE | 500mg, 850mg Film-coated tablets | Diabetes drugs | Q1-2023 |
| METHOTREXATE | 2.5 mg Film-coated tablets | Antineoplastic agents | YES |
| METRONIDAZOLE | 200mg, 250mg, 400mg, 500mg Film-coated tablets | Antibacterials | Q2-2025 |
| METHYLDOPA | 250 mg Film-coated tablets | Antihypertensives | Q4-2022 |
| NAPROXEN | 250mg, 500mg Tablets | Antiinflammatory & antirheumatics | Q2-2023 |
| NIFEDIPINE | 10mg Film-coated tablets | Calcium channel blockers | Q4-2024 |
| NIFEDIPINE | 20mg Prolonged-release tablets | Calcium channel blockers | Q4-2025 |
| NORETHISTERONE | 5mg Tablets | Sex hormones and modulators of the genital system | Q1-2023 |
| PAZOPANIB (as hydrochloride) ** | 200mg, 400mg Film-coated tablets | Antineoplastic agents | YES |
| PHENOXYMETHYLPENICILLIN | 800mg, 1000mg Film-coated tablets | Antibacterials | YES |
| PREGABALIN | 25mg, 75mg, 150mg, 300mg Capsules, hard | Antiepileptics | Q3-2022 |
| RASAGILINE ** | 1mg Tablets | Antiparkinsons drugs | YES |
| RITONAVIR/ ATAZANAVIR (as sulfate) ** | 100/200mg, 100/300mg Film-coated tablets | Antivirals | Q4-2021 |
| RIVAROXABAN | 2.5mg, 10mg, 15mg, 20mg Film-coated tablets | Antithrombotic agents | Q3-2021 |
| SILDENAFIL | 25mg, 50mg, 100mg Film-coated tablets | Erectile dysfunction agents | Q4-2022 |
| SITAGLIPTIN (as Hydrochloride monohydrate) | 25mg, 50mg, 100mg Film-coated tablets | Diabetes drugs | YES |
| SITAGLIPTIN (as Hydrochloride monohydrate) / METFORMIN HYDROCHLORIDE | 50mg/850mg, 50mg/1000mg Film-coated tablets | Diabetes drugs | YES |
| SORAFENIB ** | 200mg Film-coated tablets | Antineoplastic agents | YES |
| SPIRONOLACTONE | 25mg, 100mg Film-coated tablets | Diuretics | Q2-2023 |
| SULPIRIDE | 50mg, 200mg Tablets | Antipsychotics | Q1-2024 |
| SUMATRIPTAN | 50mg, 100mg Film-coated Tablets | Analgesics | Q2-2023 |
| SUNITINIB ** | 12.5mg, 25mg, 37.5mg, 50mg Capsules, hard | Antineoplastic agents | YES |
| TAMOXIFEN | 10mg, 20mg Tablets | Antineoplastic agents | Q1-2024 |
| TENOFOVIR DISOPROXIL ** | 123mg, 163mg, 204mg, 245mg Film-coated tablets | Antivirals | YES |
| TERBINAFINE | 250mg Tablets | Antifungals | YES |
| TICAGLEROR | 60mg, 90mg Film-coated tablets | Antithrombotic agents | Q1-2022 |
| TINIDAZOLE | 500mg Film-coated tablets | Antibacterials | Q4-2024 |
| VERAPAMIL | 40mg, 80mg Coated tablets | Calcium channel blockers | Q3-2025 |
| GENERIC NAME | STRENGTH and DOSAGE FORM | THERAPEUTIC CATEGORY | DOSSIER AVAILABILITY |
* Informations sur les brevets : La disponibilité de ces produits est soumise à des restrictions de brevet dans les pays où les brevets applicables sont en vigueur.